Bendamustine is a compound containing a benzimidazole core, used as an active pharmaceutical ingredient in the manufacturing of antineoplastic medications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 16506-27-7
Bendamustine hydrochloride
pharmaceutical raw material
1H-Benzimidazole-2-butanoic acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, 2-((2-(3-carboxypropyl)-1-methyl-1H-benzimidazol-5-yl)(2-chloroethyl)amino)ethyl ester
pharmaceutical intermediate
25-cyclohexyl-4'-O-de(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-5-(hydroxyimino)avermectin A1a
pharmaceutical raw material
Linezolid
pharmaceutical raw material
Zoledronic acid monohydrate
pharmaceutical raw material
Oxedrine tartrate
pharmaceutical raw material
4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid
YTKUWDBFDASYHO-UHFFFAOYSA-N
CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O